Patents by Inventor Robert Raymond Bulger

Robert Raymond Bulger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12070610
    Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary, a secondary, and a tertiary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the integral leads are inserted through the primary incision and routed subcutaneously to desired nerve regions along desired paths. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve regions and at least three of the nerves associated therewith to achieve a desired pain reduction response from the patient.
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: August 27, 2024
    Assignee: Shiratronics, Inc.
    Inventors: Kenneth Lyle Reed, Robert Raymond Bulger, Paul Griffith, Bob Ozawa, Navin Bunyan
  • Publication number: 20230191136
    Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary, a secondary, and a tertiary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the integral leads are inserted through the primary incision and routed subcutaneously to desired nerve regions along desired paths. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve regions and at least three of the nerves associated therewith to achieve a desired pain reduction response from the patient.
    Type: Application
    Filed: February 14, 2023
    Publication date: June 22, 2023
    Inventors: Kenneth Lyle Reed, Robert Raymond Bulger, Paul Griffith, Bob Ozawa, Navin Bunyan
  • Patent number: 11623100
    Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary, a secondary, and a tertiary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the integral leads are inserted through the primary incision and routed subcutaneously to desired nerve regions along desired paths. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve regions and at least three of the nerves associated therewith to achieve a desired pain reduction response from the patient.
    Type: Grant
    Filed: March 3, 2021
    Date of Patent: April 11, 2023
    Assignee: Shiratronics, Inc.
    Inventors: Kenneth Lyle Reed, Robert Raymond Bulger, Paul Griffith, Bob Ozawa, Navin Bunyan
  • Patent number: 11612756
    Abstract: An implantable head-mounted unibody peripheral neurostimulation system is provided for implantation in the head for the purpose of treating chronic head pain, including migraine. The system may include an implantable pulse generator (IPG) from which multiple stimulating leads may extend sufficient to allow for adequate stimulation over multiple regions of the head, preferably including the frontal, parietal and occipital regions. A lead may include an extended body, along which may be disposed a plurality of surface metal electrodes, which may be sub-divided into a plurality of electrode arrays. A plurality of internal metal wires may run a portion of its length and connect the IPG's internal circuit to the surface metal electrodes. The IPG may include a rechargeable battery, an antenna, and an application specific integrated circuit. The IPG may be capable of functional connection with an external radiofrequency unit for purposes that may include recharging, diagnostic evaluation, and programming.
    Type: Grant
    Filed: February 5, 2021
    Date of Patent: March 28, 2023
    Assignee: Shiratronics, Inc.
    Inventors: Kenneth Lyle Reed, Robert Raymond Bulger
  • Publication number: 20220257956
    Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.
    Type: Application
    Filed: May 9, 2022
    Publication date: August 18, 2022
    Inventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes
  • Patent number: 11400302
    Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the primary integral lead is inserted through the primary incision and routed subcutaneously to a first desired nerve region along a first desired path. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve region and at least one of the nerves associated therewith to achieve a desired pain reduction response from the patient.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: August 2, 2022
    Assignee: Shiratronics, Inc.
    Inventors: Kenneth Lyle Reed, Robert Raymond Bulger, Michael Steven Colvin, Claire Denault
  • Patent number: 11357995
    Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: June 14, 2022
    Assignee: Shiratronics, Inc.
    Inventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes
  • Publication number: 20210187304
    Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary, a secondary, and a tertiary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the integral leads are inserted through the primary incision and routed subcutaneously to desired nerve regions along desired paths. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve regions and at least three of the nerves associated therewith to achieve a desired pain reduction response from the patient.
    Type: Application
    Filed: March 3, 2021
    Publication date: June 24, 2021
    Inventors: Kenneth Lyle Reed, Robert Raymond Bulger, Paul Griffith, Bob Ozawa, Navin Bunyan
  • Publication number: 20210162219
    Abstract: An implantable head-mounted unibody peripheral neurostimulation system is provided for implantation in the head for the purpose of treating chronic head pain, including migraine. The system may include an implantable pulse generator (IPG) from which multiple stimulating leads may extend sufficient to allow for adequate stimulation over multple regions of the head, preferably including the frontal, parietal and occipital regions. A lead may include an extended body, along which may be disposed a plurality of surface metal electrodes, which may be sub-divided into a plurality of electrode arrays. A plurality of internal metal wires may run a portion of its length and connect the IPG's internal circuit to the surface metal electrodes. The IPG may include a rechargeable battery, an antenna, and an application specific integrated circuit. The IPG may be capable of functional connection with an external radiofrequency unit for purposes that may include recharging, diagnostic evaluation, and programming.
    Type: Application
    Filed: February 5, 2021
    Publication date: June 3, 2021
    Inventors: Kenneth Lyle Reed, Robert Raymond Bulger
  • Patent number: 10960215
    Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary, a secondary, and a tertiary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the integral leads are inserted through the primary incision and routed subcutaneously to desired nerve regions along desired paths. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve regions and at least three of the nerves associated therewith to achieve a desired pain reduction response from the patient.
    Type: Grant
    Filed: November 21, 2018
    Date of Patent: March 30, 2021
    Assignee: NUXCEL, INC.
    Inventors: Kenneth Lyle Reed, Robert Raymond Bulger, Paul Griffith, Bob Ozawa, Navin Bunyan
  • Patent number: 10946205
    Abstract: An implantable head-mounted unibody peripheral neurostimulation system is provided for implantation in the head for the purpose of treating chronic head pain, including migraine. The system may include an implantable pulse generator (IPG) from which multiple stimulating leads may extend sufficient to allow for adequate stimulation over multiple regions of the head, preferably including the frontal, parietal and occipital regions. A lead may include an extended body, along which may be disposed a plurality of surface metal electrodes, which may be sub-divided into a plurality of electrode arrays. A plurality of internal metal wires may run a portion of its length and connect the IPG's internal circuit to the surface metal electrodes. The IPG may include a rechargeable battery, an antenna, and an application specific integrated circuit. The IPG may be capable of functional connection with an external radiofrequency unit for purposes that may include recharging, diagnostic evaluation, and programming.
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: March 16, 2021
    Assignee: NUXCEL, INC.
    Inventors: Kenneth Lyle Reed, Robert Raymond Bulger
  • Publication number: 20210046319
    Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the primary integral lead is inserted through the primary incision and routed subcutaneously to a first desired nerve region along a first desired path. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve region and at least one of the nerves associated therewith to achieve a desired pain reduction response from the patient.
    Type: Application
    Filed: October 30, 2020
    Publication date: February 18, 2021
    Inventors: Kenneth Lyle Reed, Robert Raymond Bulger, Michael Steven Colvin, Claire Denault
  • Patent number: 10850112
    Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the primary integral lead is inserted through the primary incision and routed subcutaneously to a first desired nerve region along a first desired path. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve region and at least one of the nerves associated therewith to achieve a desired pain reduction response from the patient.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: December 1, 2020
    Assignee: NUXCEL, INC.
    Inventors: Kenneth Lyle Reed, Robert Raymond Bulger, Michael Steven Colvin, Claire Denault
  • Publication number: 20200289833
    Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.
    Type: Application
    Filed: May 29, 2020
    Publication date: September 17, 2020
    Inventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes
  • Patent number: 10695571
    Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: June 30, 2020
    Assignee: NUXCEL, INC.
    Inventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes
  • Patent number: 10258805
    Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary, a secondary, and a tertiary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the integral leads are inserted through the primary incision and routed subcutaneously to desired nerve regions along desired paths. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve regions and at least three of the nerves associated therewith to achieve a desired pain reduction response from the patient.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: April 16, 2019
    Assignee: SYNTILLA MEDICAL, LLC
    Inventors: Kenneth Lyle Reed, Robert Raymond Bulger, Michael Steven Colvin
  • Publication number: 20190091480
    Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary, a secondary, and a tertiary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the integral leads are inserted through the primary incision and routed subcutaneously to desired nerve regions along desired paths. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve regions and at least three of the nerves associated therewith to achieve a desired pain reduction response from the patient.
    Type: Application
    Filed: November 21, 2018
    Publication date: March 28, 2019
    Inventors: Kenneth Lyle REED, Robert Raymond BULGER, Paul GRIFFITH, Bob OZAWA, Navin BUNYAN
  • Publication number: 20180256903
    Abstract: An implantable head-mounted unibody peripheral neurostimulation system is provided for implantation in the head for the purpose of treating chronic head pain, including migraine. The system may include an implantable pulse generator (IPG) from which multiple stimulating leads may extend sufficient to allow for adequate stimulation over multple regions of the head, preferably including the frontal, parietal and occipital regions. A lead may include an extended body, along which may be disposed a plurality of surface metal electrodes, which may be sub-divided into a plurality of electrode arrays. A plurality of internal metal wires may run a portion of its length and connect the IPG's internal circuit to the surface metal electrodes. The IPG may include a rechargeable battery, an antenna, and an application specific integrated circuit. The IPG may be capable of functional connection with an external radiofrequency unit for purposes that may include recharging, diagnostic evaluation, and programming.
    Type: Application
    Filed: May 14, 2018
    Publication date: September 13, 2018
    Inventors: KENNETH LYLE REED, ROBERT RAYMOND BULGER
  • Publication number: 20180236245
    Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.
    Type: Application
    Filed: February 9, 2018
    Publication date: August 23, 2018
    Inventors: HARRY DELLAMANO, KENNETH LYLE REED, ROBERT RAYMOND BULGER, CLAIRE DENAULT, MICHAEL STEVEN COLVIN, PAUL GRIFFITH, FRANCIS MENEZES
  • Publication number: 20180221664
    Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the primary integral lead is inserted through the primary incision and routed subcutaneously to a first desired nerve region along a first desired path. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve region and at least one of the nerves associated therewith to achieve a desired pain reduction response from the patient.
    Type: Application
    Filed: February 6, 2018
    Publication date: August 9, 2018
    Inventors: KENNETH LYLE REED, ROBERT RAYMOND BULGER, MICHAEL STEVEN COLVIN, CLAIRE DENAULT